(Q43256130)

17 November 2017

title

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders (English)

1 reference

17 November 2017

1 reference

1 reference

1 reference

6

Fred Poordad

0 references

Nezam Afdhal

object named as

Nezam Afdhal

5

0 references

Lindsay McNair

11

object named as

Lindsay McNair

1 reference

17 November 2017

Vinod K Rustgi

1

1 reference

17 November 2017

William M Lee

2

1 reference

17 November 2017

Eric Lawitz

3

1 reference

17 November 2017

Stuart C Gordon

4

1 reference

17 November 2017

Herbert L Bonkovsky

7

1 reference

17 November 2017

Leif Bengtsson

8

1 reference

17 November 2017

Gurudatt Chandorkar

9

1 reference

17 November 2017

Matthew Harding

10

1 reference

17 November 2017

Molly Aalyson

12

1 reference

17 November 2017

John Alam

13

1 reference

17 November 2017

Robert Kauffman

14

1 reference

17 November 2017

Shahin Gharakhanian

15

1 reference

17 November 2017

John G McHutchison

16

1 reference

17 November 2017

MErimepodib TRiple cOmbination Study Group

17

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

50

1 reference

17 November 2017

issue

6

1 reference

17 November 2017

page(s)

1719-1726

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

17 November 2017

cites work

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Chronic hepatitis C: treatment of pegylated interferon/ribavirin nonresponders

21 January 2018

1 reference

Treating HCV with ribavirin analogues and ribavirin-like molecules

21 January 2018

1 reference

Activation and deactivation of a broad-spectrum antiviral drug by a single enzyme: adenosine deaminase catalyzes two consecutive deamination reactions

21 January 2018

1 reference

Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon

21 January 2018

1 reference

The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.

21 January 2018

1 reference

Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C.

21 January 2018

1 reference

Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent

21 January 2018

1 reference

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

21 January 2018

1 reference

Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation

21 January 2018

1 reference

Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha

21 January 2018

1 reference

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.23204

1 reference

17 November 2017

1 reference